These results, along with a past report showing that a small-molecule ACKR3 agonist CCX771 reveals anxiolytic-like conduct in mice,2 help the principle of concentrating on ACKR3 as a unique solution to modulate the opioid procedure, which could open up new therapeutic avenues for opioid-associated Diseases. Disclaimer: The above can https://jackd046jlf7.blogpayz.com/profile